These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 9038139

  • 21. Purification of vesicular monoamine transporters: from classical techniques to histidine tags.
    Yelin R, Schuldiner S.
    Methods Enzymol; 1998; 296():64-72. PubMed ID: 9779440
    [No Abstract] [Full Text] [Related]

  • 22. Ligand recognition by the vesicular monoamine transporters.
    Finn JP, Merickel A, Peter D, Edwards RH.
    Adv Pharmacol; 1998; 42():232-6. PubMed ID: 9327886
    [No Abstract] [Full Text] [Related]

  • 23. A molecular glimpse of vesicular monoamine transporters.
    Schuldiner S.
    J Neurochem; 1994 Jun; 62(6):2067-78. PubMed ID: 7910628
    [No Abstract] [Full Text] [Related]

  • 24. An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles.
    Waites CL, Mehta A, Tan PK, Thomas G, Edwards RH, Krantz DE.
    J Cell Biol; 2001 Mar 19; 152(6):1159-68. PubMed ID: 11257117
    [Abstract] [Full Text] [Related]

  • 25. Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.
    Zucker M, Weizman A, Rehavi M.
    Life Sci; 2001 Sep 28; 69(19):2311-7. PubMed ID: 11669473
    [Abstract] [Full Text] [Related]

  • 26. Mutagenesis and derivatization of human vesicle monoamine transporter 2 (VMAT2) cysteines identifies transporter domains involved in tetrabenazine binding and substrate transport.
    Thiriot DS, Ruoho AE.
    J Biol Chem; 2001 Jul 20; 276(29):27304-15. PubMed ID: 11375404
    [Abstract] [Full Text] [Related]

  • 27. Molecular pharmacology of the vesicular monoamine transporter.
    Henry JP, Sagné C, Botton D, Isambert MF, Gasnier B.
    Adv Pharmacol; 1998 Jul 20; 42():236-9. PubMed ID: 9327887
    [No Abstract] [Full Text] [Related]

  • 28. The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters.
    Yelin R, Schuldiner S.
    FEBS Lett; 1995 Dec 18; 377(2):201-7. PubMed ID: 8543051
    [Abstract] [Full Text] [Related]

  • 29. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
    Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):5166-71. PubMed ID: 8643547
    [Abstract] [Full Text] [Related]

  • 30. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles.
    Varoqui H, Erickson JD.
    J Physiol Paris; 1998 Apr 14; 92(2):141-4. PubMed ID: 9782458
    [Abstract] [Full Text] [Related]

  • 31. Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals.
    Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM.
    Synapse; 1997 Jun 14; 26(2):194-8. PubMed ID: 9131778
    [Abstract] [Full Text] [Related]

  • 32. A phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles.
    Krantz DE, Waites C, Oorschot V, Liu Y, Wilson RI, Tan PK, Klumperman J, Edwards RH.
    J Cell Biol; 2000 Apr 17; 149(2):379-96. PubMed ID: 10769030
    [Abstract] [Full Text] [Related]

  • 33. Transport mechanisms in acetylcholine and monoamine storage.
    Parsons SM.
    FASEB J; 2000 Dec 17; 14(15):2423-34. PubMed ID: 11099460
    [Abstract] [Full Text] [Related]

  • 34. Peptide mapping of the [125I]Iodoazidoketanserin and [125I]2-N-[(3'-iodo-4'-azidophenyl)propionyl]tetrabenazine binding sites for the synaptic vesicle monoamine transporter.
    Sievert MK, Ruoho AE.
    J Biol Chem; 1997 Oct 10; 272(41):26049-55. PubMed ID: 9325342
    [Abstract] [Full Text] [Related]

  • 35. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.
    Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG.
    Neuron; 1997 Dec 10; 19(6):1285-96. PubMed ID: 9427251
    [Abstract] [Full Text] [Related]

  • 36. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
    Miller DK, Crooks PA, Zheng G, Grinevich VP, Norrholm SD, Dwoskin LP.
    J Pharmacol Exp Ther; 2004 Sep 10; 310(3):1035-45. PubMed ID: 15121762
    [Abstract] [Full Text] [Related]

  • 37. Identification of a novel, inhibitory action of amiodarone on vesicular monoamine transport.
    Haikerwal D, Dart AM, Little PJ, Kaye DM.
    J Pharmacol Exp Ther; 1999 Feb 10; 288(2):834-7. PubMed ID: 9918596
    [Abstract] [Full Text] [Related]

  • 38. Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones.
    Rehavi M, Goldin M, Roz N, Weizman A.
    Brain Res Mol Brain Res; 1998 Jun 01; 57(1):31-7. PubMed ID: 9630494
    [Abstract] [Full Text] [Related]

  • 39. Gastrin induces expression and promoter activity of the vesicular monoamine transporter subtype 2.
    Gerhard M, Neumayer N, Presecan-Siedel E, Zanner R, Lengyel E, Cramer T, Höcker M, Prinz C.
    Endocrinology; 2001 Aug 01; 142(8):3663-72. PubMed ID: 11459816
    [Abstract] [Full Text] [Related]

  • 40. Expression and regulation of the bovine vesicular monoamine transporter gene.
    Krejci E, Gasnier B, Botton D, Isambert MF, Sagné C, Gagnon J, Massoulié J, Henry JP.
    FEBS Lett; 1993 Nov 29; 335(1):27-32. PubMed ID: 7902299
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.